Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells. - Wikidata - awgldk - TriplyDB

Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

http://www.wikidata.org/entity/Q34621654

about

Designing Herpes Viruses as Oncolytics.Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus Rethinking herpes simplex virus: the way to oncolytic agents.Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress Retargeting of herpes simplex virus (HSV) vectors.Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor.Postexit surface engineering of retroviral/lentiviral vectors.

P2860

Q36142487-449A0B89-934C-4C29-9D7D-2B2C71FC533E Q36659325-2FDAE8C6-B64F-4C13-A92C-2B55AE722135 Q37882608-038D7E9E-9E5F-4197-8B93-50522BE8AC31 Q37899230-C753AC8C-D1E7-447C-900B-2CCB4EA83D12 Q38950892-D79CD303-31C7-4772-9E63-1EFA488170D8 Q39339386-52CB7AE3-8917-425D-BED1-606E67AD63DA Q39580061-0054809D-5EDF-4B8C-BC1F-9D483D406523 Q44035393-B6F019DB-F670-46E6-9A6E-BBFB69686E82

P2860

Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

http://www.wikidata.org/entity/Q34621654

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@ast

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@en

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@nl

type

label

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@ast

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@en

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@nl

prefLabel

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@ast

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@en

Bispecific adapter-mediated re ...... or to CEA-bearing tumor cells.

@nl

P1433

Q34621654-32B2569A-5F3D-4939-8248-F38861C0C12A

P1476

Q34621654-03B9A092-D163-48E2-9832-A37F7C18A8AA

P2093

Q34621654-05CE4C11-7A37-48C3-A9E9-E67D6E5951FB

Q34621654-16B299BF-FB2D-4625-B34B-E751BD8872F0

Q34621654-205197EC-604C-4ADD-B0A6-AC1559F3FCE7

Q34621654-45785B00-0492-4D39-ACAE-88B995DF83C7

Q34621654-478380AB-CB96-4873-A054-488380F4100C

Q34621654-8C7A6334-5430-417C-9998-38730277E2F4

P2860

Q34621654-03C482CC-BCD7-4482-834D-B320F88CBCA5

Q34621654-04D44C9C-8898-4276-910C-CDD53B7AD0C0

Q34621654-080E89AD-BC2F-4617-99AD-2AA760B5738B

Q34621654-0B3B921F-7470-4485-8C3E-374955E468A7

Q34621654-1B3D158F-E9FE-4F7F-8C94-B5B0146EEC89

Q34621654-1BFE106A-DCFD-4AEE-94B1-22B5BAD7EA5D

Q34621654-23A5992A-A77E-49B0-99E6-79472FA834D3

Q34621654-243E256B-C37F-45FD-AD76-E49473BAE655

Q34621654-38AC652E-3261-49A8-8BA7-D6F957AA82C9

Q34621654-4A6C781A-1DFA-49D3-97FF-0F4B5624432A

P304

Q34621654-3FAA1D34-5D69-406E-AC61-674253C6A05E

P31

Q34621654-810FA6B4-CF2F-4138-9019-99DD602BE86A

P356

Q34621654-BB34C05B-4895-4097-BDD8-DC07AF36561D

P433

Q34621654-A4365C54-9801-4121-993F-16A41C34F154

P478

Q34621654-46F62519-204E-40F3-A29E-6C760DB04A87

P50

Q34621654-3ADA98DF-216D-40B3-B749-B519123822FB

Q34621654-E4E9EBA2-0003-49A9-96C0-A300C7BF824C

P577

Q34621654-BDFFFD34-1400-45AF-BCAD-83FF0306C5CE

P5875

Q34621654-CE12EFB3-8EB3-4A4D-B839-0B4FFF169B58

P698

Q34621654-3B9127DE-6E9A-434C-94CE-479B6004B446

P932

Q34621654-5FABEDBE-7CD4-4823-916D-8062FB8B3CC3

P356

P1433

Molecular Therapy

P1476

Bispecific adapter-mediated re ...... tor to CEA-bearing tumor cells

@en

P2093

Heechung Kwon

http://www.w3.org/2001/XMLSchema#string

Hiroaki Uchida

http://www.w3.org/2001/XMLSchema#string

Jae-Hong Kim

http://www.w3.org/2001/XMLSchema#string

Joseph C Glorioso

http://www.w3.org/2001/XMLSchema#string

Kyungok Jun

http://www.w3.org/2001/XMLSchema#string

Masahide Kuroki

http://www.w3.org/2001/XMLSchema#string

P2860

PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B

Molecular cloning of nonspecific cross-reacting antigens in human granulocytes

ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1

Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1/HveC/HIgR) and nectin2 (PRR2/HveB)

Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

P304

507-514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.207

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Justus B. Cohen

P577

2010-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47349813

http://www.w3.org/2001/XMLSchema#string

P698

20924362

http://www.w3.org/2001/XMLSchema#string

P932

3048173

http://www.w3.org/2001/XMLSchema#string